Correlation between serum prealbumin and prognosis of patients with hepatocellular carcinoma after hepatectomy.


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
May 2019
Historique:
received: 24 10 2018
accepted: 30 12 2018
pubmed: 17 1 2019
medline: 18 4 2019
entrez: 17 1 2019
Statut: ppublish

Résumé

To determine whether serum prealbumin levels are associated with long-term survival after hepatectomy in patients with primary hepatocellular carcinoma(HCC). A consecutive sample of 526 patients with HCC who underwent potentially curative hepatectomy from August 2007 to August 2010 was retrospectively analyzed. Patients were classified as having normal or reduced serum prealbumin based on cut-off values of 200 or 182 mg/L. Multivariate analysis identified the preoperative level of serum prealbumin as an independent prognostic factor of long-term survival (P < 0.05): Survival was significantly better for those with normal levels than for those with reduced levels, based on either cut-off value. Similar results were observed in subgroup analyses based on the degree of cirrhosis, level of ɑ-fetoprotein and Barcelona Clinic Liver Cancer stage. Preoperative level of serum prealbumin may be useful for predicting long-term survival in patients with HCC after hepatectomy.

Identifiants

pubmed: 30648280
doi: 10.1002/jso.25378
doi:

Substances chimiques

Biomarkers 0
Prealbumin 0
alpha-Fetoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

794-800

Subventions

Organisme : Guangxi University of Science and Technology Research Projects
ID : KY2015LX056
Organisme : Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province
ID : GZZC15-34
Organisme : Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province
ID : Z2015621
Organisme : Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province
ID : Z2016512
Organisme : Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province
ID : Z2016479
Organisme : Graduate Course Construction Project of Guangxi Medical University
ID : YJSA2017014
Organisme : Foundation Ability Enhancement Project for Young Teachers in Guangxi Universities
ID : 2018KY0122
Organisme : Guangxi Natural Science Foundation
ID : 2018GXNSFBA138018
Organisme : National Science Fund Subsidized Project, Grant/Award Number: 81060173
Organisme : Innovation Project of Guangxi Graduate Education
ID : YCSW2018107
Organisme : Medical and Health Care Appropriate Technology Research and Development Projects of Guangxi Province
ID : S201417
Organisme : Medical and Health Care Appropriate Technology Research and Development Projects of Guangxi Province
ID : S201417-01

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Rong-Rong Jia (RR)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Jian-Hong Zhong (JH)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.

Rong-Rui Huo (RR)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Qi-Bin Su (QB)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Xiao Xiang (X)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Fu-Lin Zhao (FL)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Zhong-Bian Qin (ZB)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Jia-Hao Chen (JH)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Ying-Yang Liao (YY)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Liang Ma (L)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Bang-De Xiang (BD)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.

Chun-Yan Zhang (CY)

Experimental Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Le-Qun Li (LQ)

Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH